Synthesis and Characterization of a "Clickable" PBR28 TSPO-Selective Ligand Derivative Suitable for the Functionalization of Biodegradable Polymer Nanoparticles.

TSPO active targeting click chemistry microglia neuroinflammation polymer nanoparticles

Journal

Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216

Informations de publication

Date de publication:
28 Jun 2021
Historique:
received: 09 04 2021
revised: 21 05 2021
accepted: 22 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 7 2021
Statut: epublish

Résumé

Reactive microgliosis is a pathological hallmark that accompanies neuronal demise in many neurodegenerative diseases, ranging from acute brain/spinal cord injuries to chronic diseases, such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD) and age-related dementia. One strategy to assess and monitor microgliosis is to use positron emission tomography (PET) by exploiting radioligands selective for the 18 kDa translocator protein (TSPO) which is highly upregulated in the brain in pathological conditions. Several TSPO ligands have been developed and validated, so far. Among these, PBR28 has been widely adopted for PET imaging at both preclinical and clinical levels, thanks to its high brain penetration and high selectivity. For this reason, PBR28 represents a good candidate for functionalization strategies, where this ligand could be exploited to drive selective targeting of TSPO-expressing cells. Since the PBR28 structure lacks functional moieties that could be exploited for derivatization, in this work we explored a synthetic pathway for the synthesis of a PBR28 derivative carrying an alkyne group (PBR-alkyne), enabling the fast conjugation of the ligand through azide-alkyne cycloaddition, also known as click-chemistry. As a proof of concept, we demonstrated in silico that the derivatized PBR28 ligand maintains the capability to fit into the TSPO binding pocked, and we successfully exploited PBR-alkyne to decorate zwitterionic biodegradable polymer nanoparticles (NPs) resulting in efficient internalization in cultured microglia-like cell lines.

Identifiants

pubmed: 34203263
pii: nano11071693
doi: 10.3390/nano11071693
pmc: PMC8308144
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Amyotrophic Lateral Sclerosis Association
ID : 20-IIP-525
Organisme : U.S. Department of Defense
ID : W81XWH-17-1-0036
Organisme : University and Research (MIUR): Dipartimenti di Eccellenza Program (2018-2022)
ID : Dept. of Biology and Biotechnology "L. Spallanzani", University of Pavia

Références

RSC Adv. 2014;4(18):9003-9011
pubmed: 32051760
Eur J Pharm Sci. 2019 Nov 1;139:105047
pubmed: 31422171
Nanoscale. 2018 Dec 13;10(48):22701-22719
pubmed: 30512025
Mol Pharm. 2010 Dec 6;7(6):2255-69
pubmed: 20958082
Chem Soc Rev. 2010 Apr;39(4):1302-15
pubmed: 20309487
Neuropsychopharmacology. 2018 Aug;43(9):1832-1839
pubmed: 29777199
Neurosci Lett. 2014 Nov 7;583:159-64
pubmed: 25263790
Nucl Med Mol Imaging. 2017 Dec;51(4):283-296
pubmed: 29242722
ACS Nano. 2013 Nov 26;7(11):9881-95
pubmed: 24138479
Biomacromolecules. 2020 Sep 14;21(9):3909-3922
pubmed: 32786523
Int J Mol Sci. 2018 Jul 25;19(8):
pubmed: 30044440
Biomacromolecules. 2018 Apr 9;19(4):1314-1323
pubmed: 29522318
Nucl Med Biol. 2007 May;34(4):439-46
pubmed: 17499734
Nature. 1977 Oct 20;269(5630):702-4
pubmed: 22814
J Med Chem. 2004 Mar 25;47(7):1739-49
pubmed: 15027865
Sci Adv. 2017 Dec 06;3(12):e1701211
pubmed: 29226242
ChemMedChem. 2017 Aug 22;12(16):1261-1274
pubmed: 28771957
Nanoscale. 2019 Sep 21;11(35):16582-16591
pubmed: 31460534
Chem Rev. 2013 Jul 10;113(7):4905-79
pubmed: 23531040
J Neuroinflammation. 2014 Jan 08;11:3
pubmed: 24397957
J Neurosci. 2012 Aug 8;32(32):10809-18
pubmed: 22875916
Surg Neurol Int. 2015 Nov 16;6:171
pubmed: 26629397
Neuroimage. 2010 Feb 15;49(4):2924-32
pubmed: 19948230
J Cereb Blood Flow Metab. 2012 Jan;32(1):1-5
pubmed: 22008728
J Med Chem. 2008 Jan 10;51(1):17-30
pubmed: 18067245
Biomaterials. 2019 Jul;209:25-40
pubmed: 31026609
Neurochem Int. 2002 May;40(6):475-86
pubmed: 11850104
Anticancer Res. 2020 Oct;40(10):5371-5378
pubmed: 32988856

Auteurs

Renato Auriemma (R)

Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy.

Mattia Sponchioni (M)

Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy.

Umberto Capasso Palmiero (U)

Department of Chemistry and Applied Biosciences, ETH Zürich, Vladimir-Prelog-Weg 1-5/10, 8093 Zürich, Switzerland.

Giacomo Rossino (G)

Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.

Arianna Rossetti (A)

Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy.

Andrea Marsala (A)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Via Ferrata 9, 27100 Pavia, Italy.

Simona Collina (S)

Department of Drug Sciences, University of Pavia, Via Taramelli 12, 27100 Pavia, Italy.

Alessandro Sacchetti (A)

Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy.

Davide Moscatelli (D)

Department of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milano, Via Mancinelli 7, 20131 Milano, Italy.

Marco Peviani (M)

Department of Biology and Biotechnology "L. Spallanzani", University of Pavia, Via Ferrata 9, 27100 Pavia, Italy.
Gene Therapy Program, Dana Farber/Boston Children's Cancer and Blood Disorders Center, 450 Brookline Ave., Boston, MA 02215, USA.
Harvard Medical School, Boston, MA 02115, USA.

Classifications MeSH